Triple Cardiovascular Disease Detection With an Artificial Intelligence-enabled Stethoscope
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 200 participants.
Also called NCT05987670
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 200 participants
- Sponsor
- Registry
-
NCT05987670
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United Kingdom
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT05987670. Randomized; no masking; primary purpose diagnostic. Start 2023-10-25 (actual); primary completion 2028-06-23 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Triple Cardiovascular Disease Detection With an Artificial Intelligence-enabled Stethoscope
- Acronym
- TRICORDER
- Condition
- Heart Failure
- Condition
- Heart Valve Diseases
- Condition
- Atrial Fibrillation
- Condition
- Heart Murmurs
- Condition
- Congestive Heart Failure
- Intervention (Device)
- AI-stethoscope
- Lead sponsor
- Imperial College London
- Collaborator
- Imperial College Health Partners (ICHP)
Record details
- Record id
cardio:ct-nct05987670- Content hash
4c301545cd55bd1a2e0e42e67b92c81c10a248adb2d2b2fb269374c02e69a99d